Viz.ai Stock

www.viz.aiHealthcare / Healthcare softwareFounded: 2016Funding to Date: $253.45MM

Viz.ai, founded in 2016, is an AI-driven modern care coordination technology designed to improve how healthcare is delivered. The Viz Platform features advanced deep learning software that analyzes medical imaging, aiming to accelerate a diagnosis, and increase the speed of diffusion of medical innovation.

Register for Details

For more details on financing and valuation for Viz.ai, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Viz.ai.

Register Today

Team

Management Team

Chris Mansi
Co-Founder, Chief Executive Officer & Board Member
Julie Skaff
Chief Operating Officer
David Golan
Co-Founder, Chief Technology Officer & Board Member
Gad Sakin
Chief Product Officer and General Manager
Kurt Blasena
Chief Revenue Officer
Jayme Strauss
Chief Clinical Officer
David Kizner
Chief Privacy Officer & General Counsel
Jieun Choe
Chief Marketing Officer

Board Members

Mamoon Hamid
Kleiner Perkins
Kevin Ding
DHVC
Neil Shah
Greenoaks Capital Partners
Nikhil Sachdev
Insight Partners
Rory O'Driscoll
Scale Venture Partners

Other companies like Viz.ai in the Healthcare software sector

Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$977.06MM
Sector
Last Round Est. Valuation
$6.1B
Sector
Last Round Est. Valuation
$402.35MM
Sector
Last Round Est. Valuation
$962.09MM
Sector
Last Round Est. Valuation
$742.72MM
Sector
Last Round Est. Valuation
$920.88MM
Sector
Last Round Est. Valuation
$1.3B

News Highlights

AI model for HCM, the first of its kind, gains FDA approval
Viz.ai has received a de novo approval from the U.S. Food and Drug Administration (FDA) for its new artificial intelligence (AI) algorithm designed to identify signs of hypertrophic cardiomyopathy (HCM) in routine electrocardiograms (ECGs).
Viz.ai announces study findings demonstrating real-world impact of AI-driven stroke technology
Viz.ai has presented three new studies demonstrating the real-world impact of its AI-driven stroke technology. The studies highlight the superior performance of the Viz LVO solution in detecting large vessel occlusion on CT angiography for acute stroke, the value of data in visualising disparities in care and redistributing resources to increase access to stroke care in rural areas, and the successful implementation of Viz.ai's AI-powered solutions to assess and treat chronic subdural haematoma patients.
Viz.ai Joins the World Economic Forum as a Unicorn in the Innovator Communities
Named a Unicorn sub-community member, Viz.ai will be offering unique insights and solutions to global healthcare-related issues and how to harness the power of artificial intelligence for common good.
Updated on: Sep 30, 2023